KEYNOTE-042 Final Analysis: Pembrolizumab vs Chemotherapy in First-Line PD-L1-Positive Locally Advanced/Metastatic NSCLCKubota Kaoru, G. Lopes, Yi-Long Wu et al.|日本臨床腫瘍学会学術集会(CD-ROM)|2019Cited by 0